Molecular regulation of cognitive functions and developmental plasticity: Impact of GABAA receptors

Journal of Neurochemistry

Volumn 102, Issue 1, 2007, Pages 1-12

  Möhler, Hanns ^a,b,c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c Swiss Federal Institute of Technology Collegium Helveticum   (Switzerland)

Author keywords

Anxiety; Memory; Schizophrenia; Sensory processing; Sleep

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 6 FLUORO 2,9 DIHYDRO 9 METHYL 2 PHENYL 4 (1 PYRROLIDINYLCARBONYL) 1H PYRIDO[3,4 B]INDOL 1 ONE; 7 TERT BUTYL 3 (2,5 DIFLUOROPHENYL) 6 (2 METHYL 2H 1,2,4 TRIAZOL 3 YLMETHOXY) 1,2,4 TRIAZOLO[4,3 B]PYRIDAZINE; 8 AZIDO 5,6 DIHYDRO 5 METHYL 6 OXO 4H IMIDAZO[1,5 A][1,4]BENZODIAZEPINE 3 CARBOXYLIC ACID ETHYL ESTER; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BRETAZENIL; CLONAZEPAM; DIAZEPAM; ELB 139; ETOMIDATE; FLUMAZENIL; FLUNITRAZEPAM; GABOXADOL; INDIPLON; L 655708; OCINAPLON; PROPOFOL; TPA 003; TPA 023; UNCLASSIFIED DRUG; ZALEPLON; ZOLPIDEM;

ANTICONVULSANT ACTIVITY; ANXIETY; COGNITION; CONSCIOUSNESS; DEVELOPMENT; DRUG ACTIVITY; DRUG SENSITIVITY; HIPPOCAMPUS; HUMAN; INTERNEURON; LEARNING; MEMORY; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; REVIEW; SCHIZOPHRENIA; SEDATION; SENSORIMOTOR FUNCTION; SLEEP; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; COGNITION; CONSCIOUSNESS; GAMMA-AMINOBUTYRIC ACID; HUMANS; INTERNEURONS; LEARNING; MEMORY; MOVEMENT; NERVOUS SYSTEM; NEURONAL PLASTICITY; RECEPTORS, GABA-A; SLEEP;

EID: 34250183473     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04454.x     Document Type: Review

References (137)

1. Atack J. R., Hutson P. H., Collinson N. et al. (2005) Anxiogenic properties of an inverse agonist selective for α3 subunit-containing GABAA receptors. Br. J. Pharmacol. 144, 357 366.
2. Atack J. R., Wafford K., Tye S. J. et al. (2006a) TPA023, an agonist selective for α2- and α3-containing GABAA receptors, is a non-sedating anxiolytic in rodents and primates. J. Pharm. Exp. Ther. 316, 410 422.
3. Atack J. R., Pike A., Marshall G. et al. (2006b) The in vivo properties of pagoclone in rat are most likely mediated by 5′-hydroxy pagoclone. Neuropharmacology 50, 677 689.
4. Ator N. A. (2005) Contributions of GABAA receptor subtype selectivity to abuse liability and dependence potential of pharmacological treatments for anxiety and sleep disorders. CNS Spectr. 10, 31 39.
5. Barnard E. A., Skolnick P., Olsen R. W., Möhler H., Sieghart W., Biggio G., Braestrup C., Bateson A. N. Langer S. Z. (1998) Subtypes of γ-aminobutyric acidA receptors: classification on the bases of subunit structure and receptor function Pharmacol. Reviews 50, 291 313.
6. Bartos M., Vida I. Jonas P. (2007) Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat. Rev. Neurosci. 8, 45 56.
7. Belelli D. Lambert J. J. (2005) Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat. Rev. Neurosci. 6, 565 575.
8. Benson J., Löw K., Keist R., Möhler H. Rudolph U. (1998) Pharmacology of recombinant GABAA receptors rendered diazepam-insensitive by point-mutated α-subunits. FEBS Lett. 431, 400 404.
9. Bianchi M. T. McDonald R. L. (2003) Neurosteroids shift partial agonist activation of GABA(A) receptor channels from low- to high-efficacy gating patterns. J. Neurosci. 23, 10 934 10 943.
10. Bormann J. (2000) The "ABC" of GABA receptors. Trends Pharmacol. Sci. 21, 16 19.
11. Brickley S. G., Cull-Candy S. G. Farrant M. (1996) Development of a tonic form of synaptic inhibition in rat cerebellar granule cells resulting from persistent activation of GABAA receptors. J. Physiol. 497, 753 759.
12. Brickley S. G., Revilla V., Cull-Candy S. G., Wisden W. Farrant M. (2001) Adaptive regulation of neuronal excitability by a voltage independent potassium conductance. Nature 409, 88 92.
13. Brown N., Kerby J., Bonnert T. P., Whiting P. J. Wafford K. A. (2002) Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptors. Br. J. Pharmacol. 136, 965 974.
14. Brussaard A. B. Herbison A. E. (2000) Long-term plasticity of postsynaptic GABAA-receptor function in the adult brain: insights from the oxytocin neurone. Trends Neurosci. 23, 190 195.
15. Buzsaki G. Chrobak J. J. (1995) Temporal structure in spatially organized neuronal ensembles: a role for interneuronal networks. Curr. Opin. Neurobiol. 5, 504 510.
16. Buzsaki G. Draguhn A. (2004) Neuronal oscillations in cortical networks. Science 304, 1926 1929.
17. Campagna J. A., Miller K. W. Forman S. A. (2003) Mechanisms of actions of inhaled anesthetics. N. Engl. J. Med. 348, 2110 2124.
18. Caraiscos V. B., Elliott E. M., You-Ten K. E. et al. (2004) Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by α5 subunit-containing γ-aminobutyric acid type A receptors. Proc. Natl. Acad. Sci. USA. 101, 3662 3667.
19. Chambers M. S., Atack J. R., Carling R. W. et al. (2004) An orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABAA alpha5 receptors with cognition enhancing properties. J. Med. Chem. 47, 5829 5832.
20. Cirone J., Rosahl T. W., Reynolds D. S., Newman R. J., O'Meara G. F., Hutson P. H. Wafford K. A. (2004) Gamma-aminobutyric acid type A receptor beta 2 subunit mediates the hypothermic effect of etomidate in mice. Anesthesiology 100, 1438 1445.
21. Collins I., Moyes C., Davey W. B. et al. (2002) 3-Heteroaryl-2-pyridones: benzodiazepine site ligands with functional delectivity for alpha 2/alpha 3-subtypes of human GABA(A) receptor-ion channels. J. Med. Chem. 45, 1887 1900.
22. Collinson N., Kuenzi F. M., Jarolimek W. et al. (2002) Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the α5 subunit of the GABAA receptor. J. Neurosci. 22, 5572 5580.
23. Crestani F., Keist R., Fritschy J. M., Benke D., Vogt K., Prut L., Bluethmann H., Möhler H. Rudolph U. (2002) Trace fear conditioning involves hippocampal α5 GABAA receptors. PNAS 99, 8980 8985.
24. Dämgen K. Lüddens H. (1999) Zaleplon diaplays a selectivity to recombinant GABAA receptors different from zolpidem, zopiclone and benzodiazepines. Neurosci. Res. Comm. 25, 139 148.
25. Davies P. A., Hanna M. C., Hales T. G. Kirkness E. F. (1997) Insensitivity to anaesthetic agents conferred by a class of GABA(A) receptor subunit. Nature 385, 820 823.
26. Dawson G. R., Maubach K. A., Collinson N. et al. (2006) An inverse agonist selective for α5 subunit containing GABAA receptor enhances cognition. J. Pharm. Exptl. Therap. 316, 1335 1345.
27. Delini-Stula A. Berdah-Tordjman D. (1996) Antipsychotic effects of bretazenil, a partial benzodiazepine agonist in acute schizophrenia - a study group report. J. Psychiatr. Res. 30, 239 250.
28. Devor A., Fritschy J. M. Yarom Y. (2001) Spatial distribution and subunit composition of GABAA receptors in the inferior olivary nucleus. J. Neurophysiol. 85, 1686 1696.
29. Dias R., Sheppard W. F., Fradley R. L. et al. (2005) Evidence for a significant role of alpha3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines. J. Neurosci. 25, 10 682 10 688.
30. Engel A. K. Singer W. (2001) Temporal binding and the neural correlates of sensory awareness. Trends Cogn. Sci. 5, 16 25.
31. Engel A. K., Fries P. Singer W. (2001) Dynamic predictions: oscillations and synchrony in top-down processing. Nat. Rev. Neurosci. 2, 704 716.
32. Ernst M., Brauchart D., Boresch S. Sieghart W. (2003) Comparative modeling of GABAA receptors: limits, insights, future developments. J. Neurosci. 4, 933 943.
33. Fagiolini M. Hensch T. (2000) Inhibitory threshold for critical-period activation in primary visual cortex. Nature 404, 183 186.
34. Fagiolini M., Fritschy J. M., Löw K., Möhler H., Rudolph U. Hensch T. (2004) Specific GABAA circuits for visual cortical plasticity. Science 303, 1681 1683.
35. Ferster D. (2004) Blocking plasticity in the visual cortex. Science 303, 1619 1621.
36. Foeller E. Feldmann D. E. (2004) Synaptic basis for developmental plasticity in somatosensory cortex. Curr. Opin. Neurobiol. 14, 89 95.
37. Foster A. C., Pelleymounter M. A., Cullen M. J., Lewis D., Joppa M., Chen T. K., Bozigian H. P., Gross R. S. Gogas K. R. (2004) In vivo pharmacological characterization of indiplon, a novel pyrazolopyrimidine sedative-hypnotic. J. Pharmacol. Exp. Ther. 311, 547 559.
38. Franks N. P. Lieb W. R. (2000) The role of NMDA receptors in consciousness: what can we learn from anaesthetic mechanisms? in Neural Correlates of Consciousness: Empirical and Conceptual Questions (Metzinger T., ed pp. 265 269. MIT Press, Cambridge MA, USA.
39. Freund T. F. (2003) Interneuron diversity series: rhythm and mood in perisomatic inhibition. Trends Neurosci. 26, 489 495.
40. Freund T. F. Buzsaki G. (1996) Interneurons of the hippocampus. Hippocampus 6, 345 470.
41. Fritschy J. M. Brünig I. (2003) Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. Pharmacol. Ther. 98, 299 323.
42. Fritschy J. M. Möhler H. (1995) GABAA receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359, 154 194.
43. Fritschy J. M., Crestani F., Rudolph U. Möhler H. (2004) GABAA receptor subtypes with special reference to memory function and neurological disorders, in Excitatory Inhibitory Balance: Synapses, Circuits and Systems Plasticity (Hensch T. K. Fagiolini M., eds pp. 215 228. Kluwer Academic/Plenum Publishers, New York.
44. Gabernet L., Jadhav S. P., Feldman D. E., Carandini M. Scanziani M. (2005) Somatosensory integration controlled by dynamic thalamocortical feed-forward inhibition. Neuron 48, 315 327.
45. Gao B., Fritschy J. M., Benke D. Möhler H. (1993) Neuron-specific expression of GABAA receptor subtypes: differential associations of the α1- and α3-subunits with serotonergic and GABAergic neurons. Neuroscience 54, 881 892.
46. Geiger J. R., Lubke J., Roth A., Frotscher M. Jonas P. (1997) Submillisecond AMPA receptor-mediated signalling at a principal neuron-interneuron synapse. Neuron 18, 1009 1023.
47. Glykys J. Mody I. (2006) Hippocampal network hyperactivity after selective reduction of tonic inhibition in GABAA receptor α5 subunit-deficient mice. J. Neurophysiol. 95, 2796 2807.
48. Griebel G., Perrault G., Simiand J. et al. (2003) SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms. CNS Drug Rev. 9, 3 20.
49. Gupta A., Wang Y. Markam H. (2000) Organizing principles for a diversity of GABAergic interneurons and synapses in the neocortex. Science 287, 273 278.
50. Haefeli W., Martin J. R. Schoch P. (1990) Novel anxiolytics that act as partial agonists at benzodiazepine receptors. TIPS 11, 452 456.
51. Harris K. D., Henze D. A., Hirase H., Leinekugel X., Dragoi G., Czurko A. Buzsaki G. (2002) Spike train dynamics predicts theta-related phase precession in hippocampal pyramidal cells. Nature 417, 738 741.
52. Hauser J., Rudolph U., Keist R., Möhler H., Feldon J. Yee B. (2005) Hippocampal α5 subunit containing GABAA receptors modulate expression of prepulse inhibition. Mol Psychiatry 10, 201 207.
53. Hensch T. K. (2005) Critical period plasticity in local cortical circuits. Nat. Rev. Neurosci. 6, 877 888.
54. Hensch T. K. Stryker M. P. (2004) Columnar architecture sculped by GABA circuits in developing cat visual cortex. Science 303, 1678 1681.
55. Huckle R. (2004) Gaboxadol. Lundbeck/Merck. Curr. Opin. Investig. Drugs 5, 766 773.
56. Huntsmann M. M., Porcello D. M., Homanics G. E., DeLorey T. M. Huguenard J. R. (1999) Reciprocal inhibitory connections and network synchrony in the mammalian thalamus. Science 283, 541 543.
57. Hutcheon B., Morley P. Poulter M. O. (2000) Developmental change in GABAA receptor desensitization kinetics and its role in synapse function in rat cortical neurons. J. Pysiol. 522, 3 17.
58. Irnaten M., Walwyn W. N., Wang J. et al. (2002) Pentobarbital enhances GABAergic neurotransmission to cardiac parasympathetic neurons, which is prevented by expression of GABA(A) epsilon subunit. Anaesthesiology 97, 717 724.
59. Jurd R., Arras M., Lambert S. et al. (2003) General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit. FASEB J. 17, 250 252.
60. Jüttner R., Meier J. Grantyn R. (2001) Slow IPSC kinetics, low levels of α1 subunit expression and paired-pulse depression are distinct properties of neonatal inhibitory GABAergic synaptic connections in the mouse superior colliculus. Eur. J. Neurosci. 13, 2088 2098.
61. Kandler K. (2004) Activity-dependent organization of inhibitory circuits: lessons from the auditory system. Curr. Opin. Neurobiol. 14, 96 104.
62. Klausberger T., Roberts J. D. Somogyi P. (2002) Cell type- and input-specific differences in the number and subtypes of synaptic GABAA receptors in the hippocampus. J. Neurosci. 22, 2513 2521.
63. Klausberger T., Magill P. J., Marton L. F., Roberts J. D. B., Cobden P. M., Buzsaki G. Somogyi P. (2003) Brain state-and cell type-specific firing of hippocampal interneurons in vivo. Nature 421, 844 848.
64. Koch CH. (2004) The Quest of Consciousness, A Neurobiological Approach, pp. 87 104. Roberts and Company Publ., Englewood (USA).
65. Kopp C., Rudolph U. Tobler I. (2004a) Sleep EEG changes after zolpidem in mice. Neuroreport, 15, 2299 2302.
66. Kopp C., Rudolph U., Löw K. Tobler I. (2004b) Modulation of rhythmic brain activity by diazepam: GABA(A) receptor subtype and state specificity. Proc. Natl Acad. Sci. USA., 101, 3674 3679.
67. Krasowski M. D., Koltchine V. V., Rick C. E., Ye Q., Finn S. E. Harrison N. L. (1998) Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that for isoflurane. Mol. Pharmacol. 53, 530 538.
68. Lambert S., Arras M., Vogt K. E. Rudolph U. (2005) Isoflurane-induced surgical tolerance mediated only in part by beta3-containing GABA(A) receptors. Eur. J. Pharmacol. 516, 23 27.
69. Lancel M. Steiger A. (1999) Sleep and its modulation by drugs that affect GABAA receptor function. Angew. Chem. Int. Ed. 111, 2852 2864.
70. Langen B., Egerland U., Bernoster K., Dost R., Unverferth K. Rundfeldt C. (2005) Characterization in rats of the anxiolytic potential of ELB139 [1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a new agonist at the benzodiazepine binding site of the GABAA receptor. J. Pharmacol. Exp. Ther. 314, 717 724.
71. Lewis D. A., Hashimoto T. Volk D. W. (2005) Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 6, 312 324.
72. Liao M., Sonner J. M., Jurd R., Rudolph U., Borghese C. M., Harris R. A., Laster M. J. Eger E. I. II. (2005) Beta3-containing gamma-aminobutyric acidA receptors are not major targets for the amnesic and immobilizing actions of isoflurane. Anesth. Analg. 101, 412 418.
73. Linkenhoker B. A., von der Ohe C. G. Knudsen E. L. (2005) Anatomical traces of juvenile learning in the auditory system of adult barn owls. Nat. Neurosci. 8, 93 98.
74. Lippa A., Czobor P., Stark J. et al. (2005) Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator. Proc. Natl Acad. Sci. USA. 102, 7380 7385.
75. Llinás R. Ribary U. (2001) Consciousness and the brain. The thalamocortical dialogue in health and disease. Ann. N. Y. Acad. Sci. 929, 166 175.
76. Löw K., Crestani F., Keist R. et al. (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290, 131 134.
77. Markram H., Toledo-Rodriguez M., Wang Y., Gupta A., Silberberg G. Wu C. (2004) Interneurons of the neocortical inhibitory systems. Nat. Rev. Neurosci. 5, 793 807.
78. Marowsky A., Fritschy J. M. Vogt K. E. (2004) Functional mapping of GABAA receptor subtypes in the amygdala. Europ. J. Neurosci. 20, 1281 1289.
79. Martina M., Schultz J. H., Ehmke H., Monyer H. Jonas P. (1998) Functional and molecular differences between voltage-gated K+ channels of fast-spiking interneurons and pyramidal neurons of rat hippocampus. J. Neurosci. 18, 1811 1825.
80. McBain C. J. Fisahn A. (2001) Interneurons unbound. Nat. Rev. Neurosci. 2, 11 23.
81. McHugh T. J., Blum K. I., Tsien J. Z., Tonegawa S. Wilson M. A. (1996) Impaired hippocampal representation of space in CA1-specific NMDAR1 knockout mice. Cell 87, 1339 1349.
82. McKernan R. M., Rosahl T. W., Reynolds D. S. et al. (2000) Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype. Nat. Neurosci. 3, 587 592.
83. Metha M. R., Lee A. K. Wilson M. A. (2002) Role of experience and oscillations in transforming a rate code into a temporal code. Nature 417, 741 746.
84. Mihic S. J., Ye Q., Wick M. J. et al. (1997) Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 389, 385 389.
85. Miles R. (2000) Perspectives: neurobiology. Diversity in inhibition. Science 287, 244 246.
86. Mody I. Pearce R. A. (2004) Diversity of inhibitory neurotransmission through GABA(A) receptors. Trends Neurosci. 27, 569 575.
87. Möhler H. (2001) Functions of GABA receptors: pharmacology and pathophysiology, in Pharmacology of GABA and Glycine Neurotransmission (Möhler H., ed pp. 101 116. Springer Publishers, New York.
88. Möhler H. (2002) Pathophysiological aspects of diversity in neuronal inhibition: a new benzodiazepine pharmacology. Dialogues Clin. Neurosci. 4, 261 269.
89. Möhler H 2006) GABAA receptor diversity and pharmacology. Cell Tissue Res. 326, 505 516.
90. Möhler H., Fritschy J. M., Lüscher B., Rudolph U., Benson J. Benke D. (1996) The GABAA receptors: from subunits to diverse functions, in Ion Channels, Vol. 4 (Narahashi T., ed pp. 89 113. Plenum Press, New York.
91. Möhler H., Benke D., Fritschy J. M. Benson J. (2000) The benzodiazepine site of GABAA receptors, in GABA in The Nervous System: The View at Fifty Years (Martin D. L. Olsen R. W., eds pp. 97 112. Lippincott, Philadelphia PA.
92. Möhler H., Fritschy J. M. Rudolph U. (2002) A new benzodiazepine pharmacology. J. Pharm. Exptl. Ther. 300, 2 8.
93. Möhler H., Fritschy J. M., Vogt K., Crestani F. Rudolph U. (2005) Pathophysiology and pharmacology of GABAA receptors, in Anxiety and Anxiolytic Drugs, Handbook of Experimental Pharmacology, Vol. 169 (Holsboer F. Ströhle A., eds pp. 225 247. Springer Publishers, New York.
94. Morris R. G. M., Anderson A., Lynch G. S. Baudry M. (1986) Selective impairment of learning and blockade of long-term potentiation by an N-methyl-d-aspartate receptor antagonist AP5. Nature 319, 774 776.
95. Moss S. J. Smart T. G. (2001) Constructing inhibitory synapses. Nat. Rev. Neurosci. 2, 240 250.
96. Navarro J. F., Buron E. Martin-Lopez M. (2002) Anxiogenic-like activity of L-655,708, a selective ligand for the benzodiazepine site of GABA(A) receptors which contain the alpha-5 subunit, in the elevated plus-maze test. Prog. Neuropsychopharmacol. Biol. Psychiatry 26, 1389 1392.
97. Navarro J. F., Buron E. Martin-Lopez M. (2004) Behavioral profile of L-655 708, a selective ligand for the benzodiazepine site of GABAA receptors which contain the α5 subunit in social encounters between male mice. Aggress. Behav. 30, 319 325.
98. Nusser Z., Sieghart W., Stephenson F. A. Somogyi P. (1996) The α6 subunit of the GABAA receptor is concentrated in both inhibitory and excitatory synapses on cerebellar granule cells. J. Neurosci. 16, 103 114.
99. Nusser Z., Sieghart W. Somogyi P. (1998) Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J. Neurosci. 18, 1693 1703.
100. Nyíri G., Freund T. F. Somogyi P. (2001) Input-dependent synaptic targeting of α2 subunit containing GABAA receptors in hippocampal pyramidal cells of the rat. Eur. J. Neurosci. 13, 428 442.
101. O'Keefe J. Nadel L. (1978) The Hippocampus As A Cognitive Map, pp. 477 543. Clarendon Press, Oxford.
102. O'Keefe J. Recce M. L. (1993) Phase relationship between hippocampal place units and the EEG theta rhythm. Hippocampus 3, 317 330.
103. Paulsen O. Moser E. I. (1998) A model of hippocampal memory encoding and retrieval: GABAergic control of synaptic plasticity. Trends Neurosci. 21, 273 278.
104. Pawelzik H., Hughes D. I. Thomson A. M. (2002) Physiological and morphological diversity of immunocytochemically defined parvalbumin- and cholecystokinin-positive interneurons in CA1 of the adult rat hippocampus. J. Comp. Neurol. 443, 346 367.
105. Pirker S., Schwarzer C., Wieselthaler A., Sieghart W. Sperk G. (2000) GABAA receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101, 815 850.
106. Pöltl A., Hauer B., Fuchs K., Tretter V. Sieghart W. (2003) Subunit composition and quantitative importance of GABAA receptor subtypes in the cerebellum of mouse and rat. J. Neurochem. 87, 1444 1455.
107. Prenosil G. A., Schneider Gasser E. M., Rudolph U., Keist R., Fritschy J. M. Vogt K. E. (2006) Specific subtypes of GABAA receptors mediate phasic and tonic forms of inhibition in hippocampal pyramidal neurons. J. Neurophysiol. 96, 846 857.
108. Represa A. Ben-Ari Y. (2005) Trophic actions of GABA on neuronal development. Trends Neurosci. 28, 278 283.
109. Reynolds D. S., Rosahl T. W., Cirone J. et al. (2003) Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms. J. Neurosci. 23, 8608 8617.
110. van Rijnsoever C., Täuber M., Choulli M. K., Keist R., Rudolph U., Möhler H., Fritschy J. M. Crestani F. (2004) Requirement of α5 GABAA receptors for the development of tolerance to the sedative action of diazepam in mice. J. Neurosci. 24, 6785 6790.
111. Rudolph U. Antkowiak B. (2004) Molecular and neuronal substrates for general anaesthetics. Nat. Rev. Neurosci. 5, 709 720.
112. Rudolph U. Möhler H. (2006) GABA-based therapeutic approaches: GABAA receptor subtype functions. Curr. Opin. Pharmacol. 6, 18 23.
113. Rudolph U., Crestani F., Benke D., Brünig I., Benson J., Fritschy J. M., Martin J. R., Bluethmann H. Mohler H. (1999) Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes. Nature 401, 796 800.
114. Rudolph U., Crestani F. Möhler H. (2001) GABAA receptor subtypes: dissecting their pharmacological functions. Trends Pharmacol. Sci. 22, 188 194.
115. Scimemi A., Semyanov A., Sperk G., Kullmann D. M. Walker M. C. (2005) Multiple and plastic receptors mediate tonic GABAA receptor currents in the hippocampus. J. Neurosci. 25, 10 016 10 024.
116. Sieghart W. (2006) Subunit composition and structure of GABAA receptor subtypes, in GABA Receptor (Enna S. J. Möhler H., eds in press) Humana Press, Totowa, NJ.
117. Sieghart W. Sperk G. (2002) Subunit composition, distribution and function of GABAA receptor subtypes. Curr. Topics Med. Chem. 2, 795 816.
118. Skaggs W. E., McNaughton B. L., Wilson M. A. Barnes C. A. (1996) Theta phase precession in hippocampal neuronal populations and the compression of temporal sequences. Hippocampus 6, 149 172.
119. Sohal V. S., Keist R., Rudolph U. Huguenard J. R. (2003) Dynamic GABAA receptor subtype-specific modulation of the synchrony and duration of thalamic oscillations. J. Neurosci. 23, 3649 3657.
120. Spencer K. M., Nestor P. G., Perlmutter R. et al. (2004) Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc. Natl Acad. Sci. USA. 101, 17 288 17 293.
121. Sternfeld F., Carling R. W., Jelley R. A. et al. (2004) Selective, orally active gamma-amonobutyric acidA alpha5 receptor inverse agonists as cognition enhancers. J. Med. Chem. 47, 2176 2179.
122. Storustovu S. Ebert B. (2003) Gaboxadol: in vitro interaction studies with benzodiazepines and ethanol suggest functional selectivity. Eur. J. Pharmacol. 467, 49 56.
123. Thompson S. A., Bonnert T. P., Cagetti E., Whiting P. J. Wafford K. A. (2002) Overexpression of the GABA(A) receptor epsilon subunit results in insensitivity to anaesthetics. Neuropharmacology 43, 662 668.
124. Tobler I., Kopp C., Deboer T. Rudolph U. (2001) Diazepam-induced changes in sleep: role of the α1GABAA receptor subtype. Proc. Natl Acad. Sci. USA. 98, 6464 6469.
125. Traub R. D., Draguhn A., Whittington M. A., Baldeweg T., Bibbig A., Buhl E. H. Schmitz D. (2002) Axonal gap junctions between principal neurons: a novel source of network oscillations, and perhaps epileptogenesis. Rev. Neurosci. 13, 1 30.
126. Tsien J. Z., Huerta P. T. Tonegawa S. (1996) The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87, 1327 1338.
127. Vicini S., Ferguson C., Prybylowski K., Kralic J., Morrow A. L. Homanics G. E. (2001) GABAA receptor α1 subunit deletion prevents developmental changes of inhibitory synaptic currents in cerebellar neurons. J. Neurosci. 21, 3009 3016.
128. Wallner M., Rancher H. J. Olsen R.W. (2006) Low-dose alcohol actions on alpha4beta3delta GABAA receptors are reversed by the behavioral alcohol antagonist Ro15-4513. Proc. Natl. Acad. Sci. USA 103, 8540 8545.
129. Whiting P. J. (2003a) The GABAA receptor gene family: new opportunities for drug development. Curr. Opin. Drug Discov. Devel. 6, 648 655.
130. Whiting P. J. (2003b) GABAA receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discov. Today 8, 445 450.
131. Whiting P., Wafford K. A. McKernan R. M. (2000) Pharmacologic subtypes of GABAA receptors based on subunit composition, in GABA in the Nervous System: The View At Fifty Years (Martin D. L. Olsen R. W., eds pp. 113 126. Lippincott, Philadelphia.
132. Whittington M. A. Traub R. D. (2003) Interneuron diversity series: inhibitory interneurons and network oscillations in vitro. Trends Neurosci. 26, 676 682.
133. Whittington M. A. et al. (2000) Neuronal fast oscillations as a target site for psychoactive drugs. Pharmacol. Ther. 86, 171 190.
134. Wiesel T. N. Hubel D. H. (1963) Single cell responses in striate cortex of kittens deprived of vision in one eye. J. Neurophysiol. 26, 1003 1017.
135. Yee B. K., Hauser J., Dolgov V. V., Keist R., Möhler H., Rudolph U. Feldon J. (2004) GABA receptors containing the α5 subunit mediate the trance effect in aversive and appetitive conditioning and extinction of conditioned fear. Eur. J. Neurosci. 20, 1928 1936.
136. Yee B. K., Keist R., von Boehmer L. et al. (2005) A schizophrenia-related sensorimotor deficit links α3-containing GABAA receptors to a dopamine hyperfunction. Proc. Natl Acad. Sci. USA. 102, 17 154 17 159.
137. Zeller A., Arras M., Lazaris A., Jurd R. Rudolph U. (2005) Distinct molecular targets for the central respiratory and cardiac actions of the general anesthetics etomidate and propofol. FASEB J. 12, 1677 1679.